/HEAL.CN
HEAL.CN Stock - Restart Life Sciences Corp.
Healthcare|BiotechnologyCNQ
$0.11+4.76%
+$0.01 (+4.76%) • Dec 19
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.95
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.12
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HEAL.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.11 – $0.11
TARGET (TP)$0.13
STOP LOSS$0.10
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-1.04
52W High$0.17
52W Low$0.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $11,472 |
| Gross Profit | N/A | $25,405 | $-3,792 | $-4,998 | $1,729 |
| Gross Margin | N/A | N/A | N/A | N/A | 15.1% |
| Operating Income | $-658,515 | $-1,232,159 | $-1,938,882 | $-2,934,082 | $-1,801,500 |
| Net Income | $224,745 | $-1,224,422 | $-3,760,882 | $-2,684,619 | $-25,232,690 |
| Net Margin | N/A | N/A | N/A | N/A | -219950.2% |
| EPS | $0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.49 |
Company Overview
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HEAL.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 29, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 27, 2025 | — | — | — | — |
Q4 2024 | Nov 27, 2024 | — | $0.02 | — | — |
Q3 2024 | Aug 26, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 29, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.00 | — | — |
Q4 2023 | Dec 28, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 29, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 30, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.14 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.19 | — | — |
Latest News
Loading news...
Frequently Asked Questions about HEAL.CN
What is HEAL.CN's current stock price?
Restart Life Sciences Corp. (HEAL.CN) is currently trading at $0.11 per share. The stock has moved +4.76% today.
What is the analyst price target for HEAL.CN?
No analyst price targets are currently available for this stock.
What sector is Restart Life Sciences Corp. in?
Restart Life Sciences Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CNQ exchange.
What is HEAL.CN's market cap?
Restart Life Sciences Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does HEAL.CN pay dividends?
No, Restart Life Sciences Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAGN.CN
Algernon Pharmaceuticals Inc.
$0.08
Mkt Cap: $0.0B
APLI.TO
Appili Therapeutics Inc.
$0.02
Mkt Cap: $0.0B
APS.TO
Aptose Biosciences Inc.
$2.08
Mkt Cap: $0.0B
CDVA.CN
CordovaCann Corp.
$0.04
Mkt Cap: $0.0B
CVGR.CN
City View Green Holdings Inc.
$0.07
Mkt Cap: $0.0B
KNE.V
Kane Biotech Inc.
$0.04
Mkt Cap: $0.0B
MOOD.CN
Doseology Sciences Inc.
$0.64
Mkt Cap: $0.0B
RVV.CN
Revive Therapeutics Ltd.
$0.01
Mkt Cap: $0.0B
TILT.NE
TILT Holdings Inc.
$0.01
Mkt Cap: $0.0B
XRTX.V
XORTX Therapeutics Inc.
$0.85
Mkt Cap: $0.0B
Explore stocks similar to HEAL.CN for comparison